Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0J8P stock hub

LON/0J8P has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0J8Pis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0J8P

In the news

Latest news · LON/0J8P

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.9

P25 12.9P50 16.9P75 23.5

Trailing P/E39.1

P25 15.9P50 22.9P75 35.8

ROE72.9

P25 -54.2P50 2.1P75 13.7

ROIC46

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0J8P market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	11,000
Employees Change	220%
Employees Change Percent	2.04
Enterprise value	$33.1B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US45168D1046
Last refreshed	2026-05-10
Market cap	$32.4B
Price	$559
Price currency	USD
Rev Per Employee	306,095.45x
Sector	Healthcare
Sic	2835
Symbol	lon/0J8P
Website	https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.56%
EV Earnings	39.89x
EV/EBIT	32.27x
EV/EBITDA	28.44x
EV/FCF	40.33x
EV/Sales	10.14x
FCF yield	2.53%
Forward P/E	36.89x
P/B ratio	27.52x
P/E ratio	39.09x
P/S ratio	9.63x
PE Ratio10 Y	53.41x
PE Ratio3 Y	46.67x
PE Ratio5 Y	51.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.42%
EBITDA Margin	34.77%
FCF margin	24.37%
Gross margin	62.05%
Gross Profit	$2.1B
Gross Profit Growth	14.52%
Gross Profit Growth Q	15.94%
Gross Profit Growth3 Y	10.43%
Gross Profit Growth5 Y	10.4%
Net Income	$829.4M
Net Income Growth	22.38%
Net Income Growth Q	14.74%
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth3 Y	16.14%
Net Income Growth5 Y	10.19%
Pretax Margin	30.8%
Profit Margin	24.63%
Profit Per Employee	$75,402
Profitable Years	14
ROA	26.46
Roa5y	23.48
ROCE	66.99
ROE	72.92
Roe5y	84.36
ROIC	45.95
Roic5y	45.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	16.07%
Cagr3y	4.99%
Cagr5y	0.44%
EPS Growth	25.7
EPS Growth Q	17.23
EPS Growth Quarters	7
EPS Growth Years	3
EPS Growth3 Y	17.86
EPS Growth5 Y	11.83
FCF Growth	27.81%
FCF Growth Q	12.66%
FCF Growth3 Y	33.47%
FCF Growth5 Y	10.21%
OCF Growth	24.96%
OCF Growth Q	11.89%
OCF Growth10 Y	16.71%
OCF Growth3 Y	25.5%
OCF Growth5 Y	10.2%
Revenue Growth	13.08x
Revenue Growth Q	14.26x
Revenue Growth Quarters	45x
Revenue Growth Years	13x
Revenue Growth3 Y	9.02x
Revenue Growth5 Y	9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.35
Assets	$2.6B
Cash	$151.9M
Current Assets	$1.1B
Current Liabilities	$953.5M
Debt	$837.2M
Debt EBITDA	$0.7
Debt Equity	$0.71
Debt FCF	$1.02
Equity	$1.2B
Interest Coverage	35.89
Liabilities	$1.4B
Long Term Assets	$1.5B
Long Term Liabilities	$432M
Net Cash	$-685.3M
Net Cash By Market Cap	$-2.11
Net Debt EBITDA	$0.59
Net Debt Equity	$0.58
Net Debt FCF	$0.84
Tangible Book Value	$787M
Tangible Book Value Per Share	$9.93
WACC	12.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.12
Inventory Turnover	4.34
Net Working Capital	$500.2M
Quick ratio	0.69
Working Capital	$116.8M
Working Capital Turnover	$20.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	16.06%
200-day SMA	641.1
3Y total return	15.74%
50-day SMA	583.5
50-day SMA vs 200-day SMA	50under200
5Y total return	2.21%
All Time High	771.5
All Time High Change	-27.53%
All Time High Date	2025-11-26
All Time Low	169.3
All Time Low Change	230.29%
All Time Low Date	2018-02-09
ATR	25.4
Beta	1.57
Ch YTD	-17.82
High	592.7
High52	771.5
High52 Date	2025-11-26
High52ch	-27.53%
Low	554.8
Low52	486.5
Low52 Date	2025-05-08
Low52ch	17.76%
Ma50ch	-4.18%
Price vs 200-day SMA	-12.79%
RSI	45.59
RSI Monthly	50.85
RSI Weekly	39.82
Sharpe ratio	0.5x
Sortino ratio	1.23
Total Return	2.6%
Tr YTD	-17.82
Tr1m	-3.09%
Tr1w	-1.63%
Tr3m	-13.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.1B
Operating Income Growth	14.85
Operating Income Growth Q	11.38
Operating Income Growth3 Y	14.49
Operating Income Growth5 Y	11.86
Operating margin	31.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,012,659%
Net Borrowing	23,556,802.1
Shares Insiders	0.99%
Shares Institutions	95.43%
Shares Qo Q	-0.4%
Shares Yo Y	-2.6%
Short Ratio	3.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$773.8M
Average Volume	244.75x
Bv Per Share	14.87
CAPEX	$-95.9M
Ch1m	-3.09
Ch1w	-1.63
Ch1y	16.06
Ch3m	-13.97
Ch3y	15.74
Ch5y	2.21
Ch6m	-20.4
Change	-2.25%
Change From Open	0.78
Close	572
Days Gap	-3.01
Depreciation Amortization	109,149,083.7
Dollar Volume	10,064.2
Earnings Date	2026-05-05
EBIT	$1.1B
EBITDA	$1.2B
EPS	$10.29
F Score	7
FCF	$820.5M
FCF EV Yield	2.48x
Financing CF	-792,196,313
Fiscal Year End	December
Founded	1,983
Goodwill	302,284,053.5
Graham Number	80.86447
Graham Upside	-85.54
Income Tax	$207.7M
Investing CF	-106,153,714
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	$146
Lynch Upside	-73.93
Ma150	646
Ma150ch	-13.44%
Ma20	571.2
Ma20ch	-2.12%
Net CF	27,685,556
Open	554.8
P FCF Ratio	39.52
P OCF Ratio	35.38
Position In Range	11.41
Ppne	632,125,494.4
Price Date	2026-05-08
Price EBITDA	$27.7
Ptbv Ratio	41.2
Relative Volume	0.06x
Revenue	3,367,049,974x
SBC By Revenue	1.39x
Share Based Comp	46,754,496
Tax By Revenue	6.17x
Tax Rate	20.03%
Tr6m	-20.4%
Volume	18
Z Score	21.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0J8P pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0J8P stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0J8P?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.4%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0J8P momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-12.8%

50/200-day relationship not available

Beta (5Y)

1.57

More volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0J8P

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0J8P stock rating?

lon/0J8P is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0J8P analysis?

The full report lives at /stocks/lon/0J8P/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0J8P?

The latest report frames lon/0J8P around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0J8P page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.